JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 5, 2008; DOI: 10.1124/jpet.108.141283


0022-3565/08/3272-425-431$20.00
JPET 327:425-431, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.141283v1
327/2/425    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Hu, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Hu, X.

CARDIOVASCULAR

Effect of cGMP on Pharmacomechanical Coupling in the Uterine Artery of Near-Term Pregnant Sheep

Lubo Zhang, DaLiao Xiao, and Xiangqun Hu

Perinatal Biology Center, Soochow University School of Medicine, Suzhou, PR China (L.Z.); and Center for Perinatal Biology, Department of Pharmacology & Physiology, Loma Linda University School of Medicine, Loma Linda, California (L.Z., D.X., X.H.)

The present study examined the role of cGMP in the regulation of {alpha}1-adrenoceptor-mediated pharmacomechanical coupling in the uterine artery of near-term pregnant sheep. The cell-permeable cGMP analog 8-bromo-cGMP produced a dose-dependent relaxation of the uterine artery and shifted norepinephrine (NE) dose-response curve to the right with a decreased maximal contraction. Accordingly, 8-bromo-cGMP significantly decreased the potency and the maximal response of NE-induced inositol 1,4,5-trisphosphate (IP3) synthesis in the uterine artery. In addition, 8-bromo-cGMP significantly reduced the binding affinity of IP3 to the IP3 receptor. The density of IP3 receptors was not affected. Simultaneous measurement of intracellular Ca2+ concentrations ([Ca2+]i) and tensions in the same tissue indicated that 8-bromo-cGMP decreased NE-induced contractions by 92% but only blocked 44% [Ca2+]i. In accordance, 8-bromo-cGMP significantly decreased tension generation for a given [Ca2+]i (g/Rf340/380, 24.87 ± 3.43 versus 3.10 ± 0.35). In the absence of extracellular Ca2+, NE produced a transient increase in [Ca2+]i and contraction, which were inhibited by 8-bromo-cGMP by 47 and 76%, respectively. In contrast to NE-induced responses, 8-bromo-cGMP had no significant effects on KCl-induced [Ca2+]i and contractions. The results indicate that cGMP suppresses {alpha}1-adrenoceptor-mediated pharmacomechanical coupling in the uterine artery by inhibiting IP3 synthesis and Ca2+ release from intracellular stores, as well as inhibiting the agonist-mediated Ca2+ sensitization of myofilaments, which is likely to play an important role in the adaptation of uterine artery contractility during pregnancy.


Received May 19, 2008; accepted August 4, 2008.

Address correspondence to: Dr. Lubo Zhang, Center for Perinatal Biology, Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA 92350. E-mail: lzhang{at}llu.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.